Two new guidelines published by the American Thyroid Association in THYROID. Firstly, the “Management of Patients with Anaplastic Thyroid Cancer“, chaired by Bob Smallridge, which are found in the November issue of THYROID, are the first guidelines to be developed for this devastating disease. They are unique in many ways, including that they contain a substantial component of ethical and end-of-life content, which is tremendously important in providing high quality care to these patients. Published in the December issue of THYROID, the “Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association“, as the title implies, was a joint effort between ATA and AACE led by Jeff Garber. The major updates of the 1995 ATA guidelines on both hyper- and hypothyroidism are now current and provide the state-of-the-art for diagnosis and management of these most common of thyroid disorders. Please join me in congratulating the members of these two task forces on completion of this important work. The two documents add to the ATA library of guideline publications that set the standard for thyroid disorder diagnosis and management worldwide. See www.thyroidguidelines.net for the complete archive of guidelines and consensus statements. Guideline and consensus statement topics currently being developed and considered include Basic Science Research, Medullary Thyroid Cancer, Thyroid Hormone Replacement and Use of Thyroid Hormone Analogues; Thyroid Nodules and Differentiated Thyroid Cancer (DTC); Pediatric Thyroid Cancer, Outpatient thyroidectomy, Airways/Goiter Management , Preoperative Imaging for Thyroid Cancer Surgery and Surgery for Recurrent/Persistent DTC.
AMERICAN THYROID ASSOCIATION® , ATA® , THYROID® , CLINICAL THYROIDOLOGY® , and the distinctive circular logo are registered in the U.S. Patent and Trademark Office as trademarks of the American Thyroid Association® , Inc.